Acer Therapeutics Inc (NASDAQ:ACER)
| 0.8167 Delayed Data As of Sep 29 |  -0.0044 / -0.54%Today’s Change | 0.55 Today|||52-Week Range 4.56 | -67.46% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 2.6M | 2.9M | 0.00 | 0.00 | |
| Depreciation And Amortization | 351.4K | 238.1K | 4.0K | 27.7K | ||
| Operating Expenses | Gross Income | -- | -- | -4.0K | -27.7K | |
| General Expenses | 14.3M | 9.6M | 13.9M | 21.7M | ||
| Research And Development | 10.0M | 6.5M | 8.7M | 12.5M | ||
| Total Operating Expenses | 14.6M | 9.9M | 13.9M | 21.7M | ||
| Non-Operating Expenses | Operating Income | -12.1M | -7.0M | -13.9M | -21.7M | |
| Extraordinary Charge | 0.00 | -1.0M | 0.00 | 0.00 | ||
| Interest Expense On Debt | 2.3K | 3.3K | 245.1K | 987.00 | ||
| Other Expenses | 67.5K | 8.3K | -16.1K | 20.6K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.0M | -8.0M | -14.2M | -21.3M | |
| Net Income | -12.0M | -8.0M | -14.2M | -21.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | -- | -- | 3.7M | 8.6M | |
| Shares To Calculate EPS Diluted | -- | -- | 3.7M | 8.6M | ||
| Earnings Per Share | EPS | -- | -- | -$3.84 | -$2.49 | |
| EPS Diluted | -- | -- | -$3.84 | -$2.49 | ||
